WHO Guideline on starting ART and PrEP

The World Health Organisation has issued an early-release guideline making available two key recommendations that were developed during the revision process of the consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection due to be published in 2016. These are:

  1. Antiretroviral therapy (ART) should be initiated in everyone living with HIV at any CD4 cell count.
  2. The use of daily oral pre-exposure prophylaxis (PrEP) is recommended as a prevention choice for people at substantial risk of HIV infection as part of combination prevention approaches.


Download PDF: WHO-Guidelines-on-ARV-initiation-and-PrEP.pdf